Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


27.02.2017

2 Acta Cytol
4 AJR Am J Roentgenol
1 Ann Surg Oncol
1 Anticancer Res
1 BMC Cancer
1 Br J Cancer
2 Breast Cancer
1 Breast Cancer (Dove Med Press)
1 Breast Cancer Res
6 Breast Cancer Res Treat
3 Breast J
2 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Lett
2 Cancer Res
2 Clin Breast Cancer
1 Clin Exp Metastasis
2 Eur J Cancer
2 Eur J Surg Oncol
1 Exp Cell Res
1 Gene
2 Int J Cancer
4 J Surg Oncol
1 JAMA
2 Lancet
1 Lancet Oncol
1 Oncogene
1 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. FIELD AS, Schmitt F, Vielh P
    IAC Standardized Reporting of Breast Fine-Needle Aspiration Biopsy Cytology.
    Acta Cytol. 2017;61:3-6.
    PubMed     Text format     Abstract available

  2. ALNAJAR H, Rosen L, Javidiparsijani S, Al-Ghamdi Y, et al
    Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer.
    Acta Cytol. 2017 Feb 24. doi: 10.1159/000455115.
    PubMed     Text format     Abstract available


    AJR Am J Roentgenol

  3. AMORNSIRIPANITCH N, Mangano M, Niell BL
    Screening Mammography: Patient Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk.
    AJR Am J Roentgenol. 2017 Feb 22:1-8. doi: 10.2214/AJR.16.16779.
    PubMed     Text format     Abstract available

  4. JAVITT MC
    Section Editor's Notebook: The Future of Breast Imaging-Find It and Fix It.
    AJR Am J Roentgenol. 2017;208:245-247.
    PubMed     Text format    

  5. KRISHNAMURTHY S, Bevers T, Kuerer HM, Smith B, et al
    Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available

  6. HOOLEY RJ, Durand MA, Philpotts LE
    Advances in Digital Breast Tomosynthesis.
    AJR Am J Roentgenol. 2017;208:256-266.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  7. WADE RG, Razzano S, Sassoon EM, Haywood RM, et al
    Complications in DIEP Flap Breast Reconstruction After Mastectomy for Breast Cancer: A Prospective Cohort Study Comparing Unilateral Versus Bilateral Reconstructions.
    Ann Surg Oncol. 2017 Feb 22. doi: 10.1245/s10434-017-5807.
    PubMed     Text format     Abstract available


    Anticancer Res

  8. FUJII T, Yajima R, Kurozumi S, Higuchi T, et al
    Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma.
    Anticancer Res. 2016;36:5481-5485.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. MCKINNON CM, Mellor H
    The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B.
    BMC Cancer. 2017;17:145.
    PubMed     Text format     Abstract available


    Br J Cancer

  10. PINDER SE, Campbell AF, Bartlett JM, Marshall A, et al
    Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial.
    Br J Cancer. 2017 Feb 21. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer

  11. UOMORI T, Horimoto Y, Mogushi K, Matsuoka J, et al
    Relationship between alcohol metabolism and chemotherapy-induced emetic events in breast cancer patients.
    Breast Cancer. 2017 Feb 20. doi: 10.1007/s12282-017-0761.
    PubMed     Text format     Abstract available

  12. ALTUNDAG K
    Does longer disease-free interval affect the complete remission in metastatic breast cancer?
    Breast Cancer. 2017 Feb 16. doi: 10.1007/s12282-017-0762.
    PubMed     Text format    


    Breast Cancer (Dove Med Press)

  13. AHMED AE, Alharbi AG, Alsadhan MA, Almuzaini AS, et al
    The predictors of poor quality of life in a sample of Saudi women with breast cancer.
    Breast Cancer (Dove Med Press). 2017;9:51-58.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  14. MCCULLOUGH LE, Chen J, Cho YH, Khankari NK, et al
    Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.
    Breast Cancer Res. 2017;19:19.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  15. PARISE CA, Caggiano V
    Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
    Breast Cancer Res Treat. 2017 Feb 17. doi: 10.1007/s10549-017-4159.
    PubMed     Text format     Abstract available

  16. ZETTERLUND L, Celebioglu F, Axelsson R, de Boniface J, et al
    Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
    Breast Cancer Res Treat. 2017 Feb 17. doi: 10.1007/s10549-017-4163.
    PubMed     Text format     Abstract available

  17. VAN NIJNATTEN TJ, Simons JM, Moossdorff M, de Munck L, et al
    Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases.
    Breast Cancer Res Treat. 2017 Feb 17. doi: 10.1007/s10549-017-4157.
    PubMed     Text format     Abstract available

  18. GASTELUM GM, Iqbal C, Hilsenbeck SG, Rimawi MF, et al
    Retrospective review of genomic testing in breast cancer: Does it improve outcome?
    Breast Cancer Res Treat. 2017 Feb 21. doi: 10.1007/s10549-017-4154.
    PubMed     Text format     Abstract available

  19. LIEU TA, Ray GT, Prausnitz SR, Habel LA, et al
    Oncologist and organizational factors associated with variation in breast cancer multigene testing.
    Breast Cancer Res Treat. 2017 Feb 21. doi: 10.1007/s10549-017-4158.
    PubMed     Text format     Abstract available

  20. ZETTERLUND LH, Frisell J, Zouzos A, Axelsson R, et al
    Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
    Breast Cancer Res Treat. 2017 Feb 21. doi: 10.1007/s10549-017-4164.
    PubMed     Text format     Abstract available


    Breast J

  21. EUHUS DM
    Choosing Bilateral Mastectomy.
    Breast J. 2016;22:605-606.
    PubMed     Text format    

  22. WANG WS, Hardesty L, Borgstede J, Takahashi J, et al
    Breast Cancers Found with Digital Breast Tomosynthesis: A Comparison of Pathology and Histologic Grade.
    Breast J. 2016;22:651-656.
    PubMed     Text format     Abstract available

  23. MA XL, Kang L, Li BJ, He CN, et al
    Invasive Ductal Carcinoma Displayed "Basal-Like" Feature Arising within a Breast Fibroadenoma.
    Breast J. 2016;22:695-696.
    PubMed     Text format    


    Cancer

  24. PRINTZ C
    Investigational drug combined with chemotherapy improves response in patients with BRCA-mutant breast cancer.
    Cancer. 2017;123:722-723.
    PubMed     Text format    

  25. WONG SM, Stout NK, Punglia RS, Prakash I, et al
    Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.
    Cancer. 2017 Feb 21. doi: 10.1002/cncr.30644.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  26. KONG X
    Reply to: comment on "Meta-analysis of GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer".
    Cancer Chemother Pharmacol. 2017 Feb 22. doi: 10.1007/s00280-016-3230.
    PubMed     Text format    


    Cancer Lett

  27. ZHANG Z, Zhu Y, Wang Z, Zhang T, et al
    Yin-Yang effect of tumor infiltrating B cells in breast cancer: From mechanism to immunotherapy.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30108.
    PubMed     Text format     Abstract available


    Cancer Res

  28. RUPRECHT B, Zaal EA, Zecha J, Wu W, et al
    Lapatinib resistance in breast cancer cells is accompanied by phosphorylation-mediated reprogramming of glycolysis.
    Cancer Res. 2017 Feb 16. pii: canres.2976.2016.
    PubMed     Text format     Abstract available

  29. BAI L, Zhou B, Yang CY, Ji J, et al
    Targeted degradation of BET proteins in triple-negative breast cancer.
    Cancer Res. 2017 Feb 16. pii: canres.2622.2016.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  30. GHONCHEH M, Ziaee F, Karami M, Poorolajal J, et al
    Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
    Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30010.
    PubMed     Text format     Abstract available

  31. GU YL, Pan SM, Ren J, Yang ZX, et al
    Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
    Clin Breast Cancer. 2017 Jan 11. pii: S1526-8209(16)30256.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  32. JANDIAL R, Choy C, Levy DM, Chen MY, et al
    Astrocyte-induced Reelin expression drives proliferation of Her2+ breast cancer metastases.
    Clin Exp Metastasis. 2017 Feb 17. doi: 10.1007/s10585-017-9839.
    PubMed     Text format     Abstract available


    Eur J Cancer

  33. PULITI D, Bucchi L, Mancini S, Paci E, et al
    Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy.
    Eur J Cancer. 2017;75:109-116.
    PubMed     Text format     Abstract available

  34. MAKAMA M, Drukker CA, Rutgers EJ, Slaets L, et al
    An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint(R)).
    Eur J Cancer. 2017;75:5-13.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  35. KIDERLEN M, van de Velde CJ, Liefers GJ
    Targeted therapy in older women with breast cancer - What's the target?
    Eur J Surg Oncol. 2017 Feb 3. pii: S0748-7983(17)30109.
    PubMed     Text format     Abstract available

  36. QIAN F, Qingping Y, Linquan W, Xiaojin H, et al
    High tumor-infiltrating FoxP3+ T cells predict poor survival in estrogen receptor-positive breast cancer: A meta-analysis.
    Eur J Surg Oncol. 2017 Jan 30. pii: S0748-7983(17)30062.
    PubMed     Text format     Abstract available


    Exp Cell Res

  37. GKRETSI V, Stylianou A, Stylianopoulos T
    Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, beta-catenin and urokinase-plasminogen activator (uPA).
    Exp Cell Res. 2017 Feb 13. pii: S0014-4827(17)30064.
    PubMed     Text format     Abstract available


    Gene

  38. DEHGHAN Z, Sadeghi S, Tabatabaeian H, Ghaedi K, et al
    ESR1 single nucleotide polymorphism rs1062577 (c.*3804T>A) alters the susceptibility of breast cancer risk in Iranian population.
    Gene. 2017 Feb 16. pii: S0378-1119(17)30105-1. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Int J Cancer

  39. STROTBEK M, Schmid S, Sanchez-Gonzalez I, Boerries M, et al
    miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer.
    Int J Cancer. 2017 Feb 22. doi: 10.1002/ijc.30661.
    PubMed     Text format     Abstract available

  40. LIN X, Chen W, Wei F, Zhou BP, et al
    POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30658.
    PubMed     Text format     Abstract available


    J Surg Oncol

  41. HYAMS DM, Schuur E, Angel Aristizabal J, Bargallo Rocha JE, et al
    Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.
    J Surg Oncol. 2017 Feb 17. doi: 10.1002/jso.24561.
    PubMed     Text format     Abstract available

  42. VU JV, Llarena NC, Estevez SL, Moravek MB, et al
    Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients.
    J Surg Oncol. 2017;115:116-121.
    PubMed     Text format     Abstract available

  43. SZYNGLAREWICZ B, Kasprzak P, Donizy P, Biecek P, et al
    Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion.
    J Surg Oncol. 2016;114:548-556.
    PubMed     Text format     Abstract available

  44. LEBYA K, Garcia-Smith R, Swaminathan R, Jones A, et al
    Towards a personalized surgical margin for breast conserving surgery-Implications of field cancerization in local recurrence.
    J Surg Oncol. 2017;115:109-115.
    PubMed     Text format     Abstract available


    JAMA

  45. HERSHMAN DL
    Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
    JAMA. 2017;317:587-588.
    PubMed     Text format    


    Lancet

  46. CAMERON D, Piccart-Gebhart MJ, Gelber RD, Procter M, et al
    11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
    Lancet. 2017 Feb 16. pii: S0140-6736(16)32616.
    PubMed     Text format     Abstract available

  47. SPECHT JM, Davidson NE
    Optimal duration of trastuzumab for early HER2-positive breast cancer.
    Lancet. 2017 Feb 16. pii: S0140-6736(17)30322.
    PubMed     Text format    


    Lancet Oncol

  48. ZHANG P, Sun T, Zhang Q, Yuan Z, et al
    Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial.
    Lancet Oncol. 2017 Feb 10. pii: S1470-2045(17)30088.
    PubMed     Text format     Abstract available


    Oncogene

  49. WU MJ, Kim MR, Chen YS, Yang JY, et al
    Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCzeta pathway.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    PLoS One

  50. QIAO W, Pan L, Kou C, Li K, et al
    Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0172413.
    PubMed     Text format     Abstract available


    Radiology

  51. KUHL CK, Strobel K, Bieling H, Leutner C, et al
    Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Radiology. 2017 Feb 21:161444. doi: 10.1148/radiol.2016161444.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: